Jeff Fairman Vaxcyte, Inc. (PCVX) insider trading activity

Jeff Fairman is VP, Research of Vaxcyte, Inc.. Currently has a direct ownership of 17,143 shares of PCVX, which is worth approximately $1.33 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 519 shares (Common Stock) at a price of $26.38 per share, resulting in proceeds of $13,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K

0% 3M change

0% 12M change

Total Value Held $1.33 Million

Jeff Fairman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2022	SELL Payment of exercise price or tax liability	$13,691 $26.38 p/Share	519 Reduced 2.94%	17,143 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	6,000 Added 26.51%	16,629 Common Stock
Dec 27 2021	SELL Open market or private sale	$113,192 $23.83 p/Share	4,750 Reduced 43.54%	6,160 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 30.33%	10,910 Common Stock
Dec 20 2021	BUY Exercise of conversion of derivative security	$8,000 $1.79 p/Share	4,469 Added 29.6%	10,629 Common Stock
Dec 16 2021	SELL Open market or private sale	$103,928 $22.5 p/Share	4,619 Reduced 42.85%	6,160 Common Stock
Dec 16 2021	BUY Exercise of conversion of derivative security	$8,268 $1.79 p/Share	4,619 Added 30.0%	10,779 Common Stock

Dec 09 2021	SELL Open market or private sale	$2,948 $22.5 p/Share	131 Reduced 2.08%	6,160 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	$234 $1.79 p/Share	131 Added 2.04%	6,291 Common Stock
Oct 26 2021	SELL Open market or private sale	$107,778 $22.69 p/Share	4,750 Reduced 48.01%	5,144 Common Stock
Oct 26 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 32.44%	9,894 Common Stock
Sep 27 2021	SELL Open market or private sale	$125,020 $26.32 p/Share	4,750 Reduced 48.01%	5,144 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 32.44%	9,894 Common Stock
Aug 26 2021	SELL Open market or private sale	$119,700 $25.2 p/Share	4,750 Reduced 48.01%	5,144 Common Stock
Aug 26 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 32.44%	9,894 Common Stock
Jul 26 2021	SELL Open market or private sale	$107,825 $22.7 p/Share	4,750 Reduced 48.01%	5,144 Common Stock
Jul 26 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 32.44%	9,894 Common Stock
Jun 28 2021	SELL Open market or private sale	$116,755 $24.58 p/Share	4,750 Reduced 48.01%	5,144 Common Stock
Jun 28 2021	BUY Exercise of conversion of derivative security	$8,502 $1.79 p/Share	4,750 Added 32.44%	9,894 Common Stock
Jun 07 2021	SELL Open market or private sale	$213,750 $22.5 p/Share	9,500 Reduced 64.87%	5,144 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$8,740 $0.92 p/Share	9,500 Added 39.35%	14,644 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$4,999 $1.79 p/Share	2,793 Added 39.93%	4,201 Common Stock
Mar 26 2021	SELL Open market or private sale	$114,285 $24.06 p/Share	4,750 Reduced 77.14%	1,408 Common Stock
Mar 26 2021	BUY Exercise of conversion of derivative security	$190 $0.04 p/Share	4,750 Added 43.55%	6,158 Common Stock
Feb 26 2021	SELL Open market or private sale	$116,232 $24.47 p/Share	4,750 Reduced 77.14%	1,408 Common Stock

Jeff Fairman

VP, Research

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account